Stem Cell Transplant Trumps Fingolimod for RRMS Relapse Risk Stem Cell Transplant Trumps Fingolimod for RRMS Relapse Risk

Autologous hematopoietic stem cell transplantation is linked to significantly lower relapse rates than fingolimod in patients with relapsing-remitting multiple sclerosis. But adverse events are common.Medscape Medical News
Source: Medscape Transplantation Headlines - Category: Transplant Surgery Tags: Neurology & Neurosurgery News Source Type: news